---
title: 'Acute cannabidiol administration reduces alcohol craving and cue-induced nucleus
  accumbens activation in individuals with alcohol use disorder: the double-blind
  randomized controlled ICONIC trial'
date: '2024-12-12'
linkTitle: https://pubmed.ncbi.nlm.nih.gov/39668256/?utm_source=curl&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&fc=20220326224207&ff=20241213171208&v=2.18.0.post9+e462414
source: heidelberg[Affiliation]
description: Although alcohol use disorder (AUD) is highly prevalent, only a few medications
  are approved for its treatment leaving much room for improvement. Cannabidiol (CBD)
  might be a particularly promising candidate, with preclinical data suggesting that
  CBD is effective in targeting AUD symptoms and disease processes that drive alcohol
  use and relapse, due to its anti-craving, stress-reducing, and anti-compulsive effects.
  Here we report data from the double-blind randomized controlled ICONIC trial ...
disable_comments: true
---
Although alcohol use disorder (AUD) is highly prevalent, only a few medications are approved for its treatment leaving much room for improvement. Cannabidiol (CBD) might be a particularly promising candidate, with preclinical data suggesting that CBD is effective in targeting AUD symptoms and disease processes that drive alcohol use and relapse, due to its anti-craving, stress-reducing, and anti-compulsive effects. Here we report data from the double-blind randomized controlled ICONIC trial ...